Clinical TrialID 5445
Impaired HDL and Coronary Artery Disease in Anabolic Androgenic Steroid Users
NCT03450837
Coronary Artery Disease
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5445
- Evidence Id
- 5445
- Core Evidence Id
- 5445
- Source Clinical Trial Id
- 5431
- Herb2 Clinical Trial Id
- HBCT005431
- Nct Id
- NCT03450837
- Title
- Impaired HDL and Coronary Artery Disease in Anabolic Androgenic Steroid Users
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Coronary Artery Disease
- Study Type
- Observational
- Study Design
- Observational Model: |Time Perspective: p
- Intervention
- DIAGNOSTIC_TEST: Coronary Computed Tomography Angiography|DIAGNOSTIC_TEST: Macrophage cholesterol efflux mediated by HDL
- Intervention Allocation
- Intervention Model
- Intervention Mask
- Intervention Purpose
- Gender
- Male
- Age
- Adult
- Enrollment
- 51
- Outcome Measure
- Concentration and the functionality of HDL, Blood sample was collected in the morning (between 8:00-10:00 a.m.) after 12 hours fasting and after 30 minutes of resting for HDL concentration assessment. Determination of 14C-cholesterol efflux mediated by HDL utilized macrophages cultured cells from mice was used to test the functionality of HDL., 1 day
- Sponsor Collaborator
- University of Sao Paulo General Hospital|Fundação de Amparo à Pesquisa do Estado de São Paulo
- Funded By
- OTHER
- Location
- Other Id
- CAD-AnabolicAndrogenicSteroids
- Start Date
- 2015-04-01
- Primary Completion Date
- 2016-04-01
- Completion Date
- 2017-04-01
- First Posted
- 2018-03-01
- Results First Posted
- Last Update Posted
- 2018-03-01
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03450837
- Title Cn
- Title En
- Impaired HDL and Coronary Artery Disease in Anabolic Androgenic Steroid Users
- Bilingual Status
- semi_complete